Sa H, Shi Y, Ding C, Ma K, et al. A real-world study of the efficacy and safety of furmonertinib for patients with non-small cell lung cancer with EGFR exon 20 insertion mutations. J Cancer Res Clin Oncol 2023 Apr 1. doi: 10.1007/s00432-023-04726.
PMID: 37004599